Fig. 2

Total Hospitalization rates following the switch to aripiprazole-depot (Phase B) with the same patients treated with oral antipsychotics (Phase A). P value derived from Wilcoxon signed rank test
Total Hospitalization rates following the switch to aripiprazole-depot (Phase B) with the same patients treated with oral antipsychotics (Phase A). P value derived from Wilcoxon signed rank test